JAK2 V617F MUTATION IN PRIMARY MYELODYSPLASTIC SYNDROMES: A MULTICENTER RETROSPECTIVE STUDY

被引：0

作者：

Dahabreh, I. J. ^{[1
]}

Manola, K. ^{[2
]}

Galanopoulos, A. ^{[3
]}

Zoi, C. ^{[1
]}

Giannouli, S. ^{[4
]}

Stavropoulou, C. ^{[2
]}

Vlachadami, I. ^{[4
]}

Kalderi, K. ^{[4
]}

Fisfis, M. ^{[5
]}

Stefanoudaki, K. ^{[5
]}

Terpos, E. ^{[6
]}

Gota, V.

Kartasis, Z. ^{[7
]}

Palliou, E. ^{[1
]}

Katsigiannis, A. ^{[8
]}

Roussou, P. ^{[8
]}

Anagnostopoulos, N. ^{[3
]}

Lafioniatis, S. ^{[9
]}

Palliou, A. ^{[1
]}

Loukopoulos, D. ^{[1
]}

Sambani, C. ^{[2
]}

Voulgarelis, M. ^{[4
]}

Zoi, K. ^{[1
]}

机构：

[1] Acad Athens, Biomed Res Fdn, Athens, Greece

[2] Natl Ctr Sci Res Demokritos, Lab Cytogenet, Athens, Greece

[3] Dist Gen G Gennimatas Hosp, Dept Clin Hematol, Athens, Greece

[4] Natl Tech Univ Athens, Sch Med, Dept Pathophysiol, Athens, Greece

[5] Amalia Fleming Gen Hosp, Dept Hematol, Athens, Greece

[6] 254 Gen AF Hosp, Dept Hematol & Med Res, Athens, Greece

[7] Chalkis Gen Hosp, Dept Hematol, Chalkis, Greece

[8] Sotiria Hosp, Dept Internal Med 3, Athens, Greece

[9] Achilopoulion Hosp, Thalassemia Unit, Volos, Greece

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0800

引用

页码：323 / 323

页数：1

共 50 条

[41] JAK2 V617F mutation positives in the general population.
Bojesen, S. E.
Nielsen, C.
Birgens, H.
Nordestgaard, B. G.
Kjaer, L.
Hasselbalch, H.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[42] Absence of JAK2 V617F mutation in thalassemia intermedia patients
Taher, Ali
Shammaa, Dina
Bazarbachi, Ali
Itani, Doha
Zaatari, Ghazi
Greige, Layal
Otrock, Zaher K.
Mahfouz, Rami A. R.
MOLECULAR BIOLOGY REPORTS, 2009, 36 (06) : 1555 - 1557
[43] Absence of JAK2 V617F mutation in thalassemia intermedia patients
Ali Taher
Dina Shammaa
Ali Bazarbachi
Doha Itani
Ghazi Zaatari
Layal Greige
Zaher K. Otrock
Rami A. R. Mahfouz
Molecular Biology Reports, 2009, 36 : 1555 - 1557
[44] JAK2, the JAK2 V617F mutant and cytokine receptors
Staerk, J.
Kallin, A.
Royer, Y.
Diaconu, C. C.
Dusa, A.
Demoulin, J.-B.
Vainchenker, W.
Constantinescu, S. N.
PATHOLOGIE BIOLOGIE, 2007, 55 (02): : 88 - 91
[45] Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
Antonioli, E
Guglielmelli, P
Pancrazzi, A
Bogani, C
Verrucci, M
Ponziani, V
Longo, G
Bosi, A
Vannucchi, AM
LEUKEMIA, 2005, 19 (10) : 1847 - 1849
[46] The JAK2 V617F mutation in patients with cerebral venous thrombosis
Passamonti, S. M.
Biguzzi, E.
Cazzola, M.
Franchi, F.
Gianniello, F.
Bucciarelli, P.
Pietra, D.
Mannucci, P. M.
Martinelli, I.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (06) : 998 - 1003
[47] JAK2 V617F mutation is absent in chronic lymphocytic leukemia
Poulain, Stephanie
Merchez, Maud
Daudignon, Agnes
Simon, Marc
Duthilleul, Patrick
Morel, Pierre
LEUKEMIA & LYMPHOMA, 2006, 47 (12) : 2657 - 2658
[48] Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
E Antonioli
P Guglielmelli
A Pancrazzi
C Bogani
M Verrucci
V Ponziani
G Longo
A Bosi
A M Vannucchi
Leukemia, 2005, 19 : 1847 - 1849
[49] JAK2 V617F mutation in unexplained loss of first pregnancy
Mercier, Eric
Lissalde-Lavigne, Geraldine
Gris, Jean-Christophe
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (19): : 1984 - 1985
[50] Is the JAK2 V617F Mutation a Hallmark for Different Forms of Thrombosis?
Zerjavic, Katja
Zagradisnik, Boris
Herodez, Spela Stangler
Lokar, Lidija
Krasevac, Marjana Glaser
Vokac, Nadja Kokalj
ACTA HAEMATOLOGICA, 2010, 124 (01) : 49 - 56

← 1 2 3 4 5 →